Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Deficit (Unaudited)

v3.20.1
Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Non-controlling Interest [Member]
Total
Beginning Balance at Dec. 31, 2018 $ 33,661 $ 3,566,339 $ (9,296,408) $ (370,132) $ (6,066,540)
Beginning Balance, Shares at Dec. 31, 2018 33,661,388        
Purchase Accounting entries due to the purchase transaction $ 9 $ 24,717 6,442,182 6,466,908
Purchase Accounting entries due to the purchase transaction, shares 9,250 24,717,217        
Adjustment for assets and liabilities not included in purchase transaction 5,244,780 5,244,780
Issuance of common stock in connection with private placement offering from January 8, 2019 through March 31, 2019 $ 17,000 4,200,946 4,217,946
Issuance of common stock in connection with private placement offering from January 8, 2019 through March 31, 2019, shares 17,000,000        
Issuance of warrants in connection with private placement offering from January 8, 2019 through March 31, 2019 2,565,638 2,565,638
Issuance of common stock pursuant to conversion of short-term debt $ 750 225,187 225,937
Issuance of common stock pursuant to conversion of short-term debt, shares 750,000        
Issuance of warrants pursuant to conversion of short-term debt in January 2019 74,063 74,063
Issuance of additional exchange shares $ 17,264 (17,264)
Issuance of additional exchange shares, shares 17,263,889        
Issuance of common stock pursuant to conversion of Preferred Series B Stock conversions $ (2) $ 513 (511)
Issuance of common stock pursuant to conversion of Preferred Series B Stock conversions, shares (2,050) 512,500        
Issuance of common stock pursuant to conversion of short-term debt and accrued interest $ 2 665 667
Issuance of common stock pursuant to conversion of short-term debt and accrued interest, shares 1,667        
Issuance of common stock in exchange for consulting fees incurred $ 130 51,904 52,034
Issuance of common stock in exchange for consulting fees incurred, shares 130,085        
Adjustment of exercise price on certain warrants 404,384 (404,384)
Beneficial conversion on Preferred Series B Stock 32,592 (32,592)
Stock based compensation 89,043 89,043
Dividends payable (24,639) (24,639)
Issuance of warrants pursuant to short-term notes, related party          
Net loss (3,694,816) (3,694,816)
Ending Balance at Mar. 31, 2019 $ 7 $ 94,037 17,610,529 (8,183,420) (370,132) 9,151,021
Ending Balance, shares at Mar. 31, 2019 7,200 94,036,746        
Beginning Balance at Dec. 31, 2018 $ 33,661 3,566,339 (9,296,408) (370,132) (6,066,540)
Beginning Balance, Shares at Dec. 31, 2018 33,661,388        
Ending Balance at Dec. 31, 2019 $ 6 $ 99,769 28,172,146 (37,362,531) (370,132) (9,460,742)
Ending Balance, shares at Dec. 31, 2019 6,100 99,768,704        
Issuance of common stock in exchange for consulting fees incurred $ 109 34,891 35,000
Issuance of common stock in exchange for consulting fees incurred, shares 109,375        
Stock based compensation 643 643
Issuance of warrants pursuant to short-term notes, related party 17,636 17,636
Deemed dividend on Series D Convertible Preferred Stock (120,940) (37,207) (158,147)
Issuance of warrants pursuant to private placement of Series D Convertible Preferred Stock 31,902 31,902
Accrued dividends on Series B Convertible Preferred Stock (18,300) (18,300)
Net loss (2,416,228) (2,416,228)
Ending Balance at Mar. 31, 2020 $ 6 $ 99,878 $ 28,117,978 $ (39,815,966) $ (370,132) $ (11,968,236)
Ending Balance, shares at Mar. 31, 2020 6,100 99,878,079